Avoiding transfusions in children undergoing cardiac surgery: a meta-analysis of randomized trials of aprotinin. (otvara novi prozor)

Arnold DM, Fergusson DA, Chan AK, Cook RJ, Fraser GA, Lim W, Blajchman MA, Cook DJ.

Izvor‎: Anesth Analg 2006;102(3):731-7.

Indeks‎: PubMed 16492820

DOI‎: 10.1213/01.ane.0000194954.64293.61

https://www.ncbi.nlm.nih.gov/pubmed/16492820 (otvara novi prozor)

A systematic review of the use of antifibrinolytic agents in pediatric surgery and implications for craniofacial use. (otvara novi prozor)

Basta MN, Stricker PA, Taylor JA.

Izvor‎: Pediatr Surg Int 2012;28(11):1059-69.

Indeks‎: PubMed 22940882

DOI‎: 10.1007/s00383-012-3167-6

https://www.ncbi.nlm.nih.gov/pubmed/22940882 (otvara novi prozor)

Aprotinin, transfusions, and kidney injury in neonates and infants undergoing cardiac surgery. (otvara novi prozor)

Bojan M, Vicca S, Boulat C, Gioanni S, Pouard P.

Izvor‎: Br J Anaesth 2012;108(5):830-7.

Indeks‎: PubMed 22362670

DOI‎: 10.1093/bja/aes002

https://www.ncbi.nlm.nih.gov/pubmed/22362670 (otvara novi prozor)

Comparison of epsilon aminocaproic acid and tranexamic acid in pediatric cardiac surgery. (otvara novi prozor)

Chauhan S, Das SN, Bisoi A, Kale S, Kiran U.

Izvor‎: J Cardiothorac Vasc Anesth 2004;18(2):141-3.

Indeks‎: PubMed 15073700

https://www.ncbi.nlm.nih.gov/pubmed/15073700 (otvara novi prozor)

Efficacy of aprotinin, epsilon aminocaproic acid, or combination in cyanotic heart disease. (otvara novi prozor)

Chauhan S, Kumar BA, Rao BH, Rao MS, Dubey B, Saxena N, Venugopal P.

Izvor‎: Ann Thorac Surg 2000;70(4):1308-12.

Indeks‎: PubMed 11081890

https://www.ncbi.nlm.nih.gov/pubmed/11081890 (otvara novi prozor)

The Bayer 022 compassionate-use pediatric study. (otvara novi prozor)

Coniff RF.

Izvor‎: Ann Thorac Surg 1998;65(6 Suppl):S31-3.

Indeks‎: PubMed 9647135

https://www.ncbi.nlm.nih.gov/pubmed/9647135 (otvara novi prozor)

Differential effects of aprotinin and tranexamic acid on outcomes and cytokine profiles in neonates undergoing cardiac surgery. (otvara novi prozor)

Graham EM, Atz AM, Gillis J, Desantis SM, Haney AL, Deardorff RL, Uber WE, Reeves ST, McGowan FX Jr, Bradley SM, Spinale FG.

Izvor‎: J Thorac Cardiovasc Surg 2012;143(5):1069-76.

Indeks‎: PubMed 22075061

DOI‎: 10.1016/j.jtcvs.2011.08.051

https://www.ncbi.nlm.nih.gov/pubmed/22075061 (otvara novi prozor)

Minimizing perioperative blood loss and transfusions in children. [Réduire les pertes sanguines et les besoins transfusionnels en chirurgie pédiatrique.] [English, French abstract] (otvara novi prozor)

Guay J, de Moerloose P, Lasne D.

Izvor‎: Can J Anaesth 2006;53(6 Suppl):S59-67.

Indeks‎: PubMed 16766791

https://www.ncbi.nlm.nih.gov/pubmed/16766791 (otvara novi prozor)

Intraoperative tranexamic acid in pediatric bloodless cardiac surgery. (otvara novi prozor)

Hasegawa T, Oshima Y, Maruo A, Matsuhisa H, Tanaka A, Noda R, Yokoyama S, Iwasaki K.

Izvor‎: Asian Cardiovasc Thorac Ann 2014;22(9):1039-45.

Indeks‎: PubMed 24637029

DOI‎: 10.1177/0218492314527991

https://www.ncbi.nlm.nih.gov/pubmed/24637029 (otvara novi prozor)

The safety and efficacy of antifibrinolytic therapy in neonatal cardiac surgery. (otvara novi prozor)

Lin CY, Shuhaiber JH, Loyola H, Liu H, Del Nido P, DiNardo JA, Pigula FA.

Izvor‎: PLoS One 2015;10(5):e0126514.

Indeks‎: PubMed 25954976

DOI‎: 10.1371/journal.pone.0126514

https://www.ncbi.nlm.nih.gov/pubmed/25954976 (otvara novi prozor)

Epsilon aminocaproic acid reduces blood transfusion and improves the coagulation test after pediatric open-heart surgery: a meta-analysis of 5 clinical trials. (otvara novi prozor)

Lu J, Meng H, Meng Z, Sun Y, Pribis JP, Zhu C, Li Q.

Izvor‎: Int J Clin Exp Pathol 2015;8(7):7978-87.

Indeks‎: PubMed 26339364

https://www.ncbi.nlm.nih.gov/pubmed/26339364 (otvara novi prozor)

Tranexamic acid versus ɛ-aminocaproic acid: efficacy and safety in paediatric cardiac surgery. (otvara novi prozor)

Martin K, Breuer T, Gertler R, Hapfelmeier A, Schreiber C, Lange R, Hess J, Wiesner G.

Izvor‎: Eur J Cardiothorac Surg 2011;39(6):892-7.

Indeks‎: PubMed 21115357

DOI‎: 10.1016/j.ejcts.2010.09.041

https://www.ncbi.nlm.nih.gov/pubmed/21115357 (otvara novi prozor)

Replacement of aprotinin by ε-aminocaproic acid in infants undergoing cardiac surgery: consequences for blood loss and outcome. (otvara novi prozor)

Martin K, Gertler R, MacGuill M, Mayr NP, Hapfelmeier A, Hörer J, Vogt M, Tassani P, Wiesner G.

Izvor‎: Br J Anaesth 2013;110(4):615-21.

Indeks‎: PubMed 23213034

DOI‎: 10.1093/bja/aes430

https://www.ncbi.nlm.nih.gov/pubmed/23213034 (otvara novi prozor)

Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations. (otvara novi prozor)

Miller BE, Tosone SR, Tam VK, Kanter KR, Guzzetta NA, Bailey JM, Levy JH.

Izvor‎: Ann Thorac Surg 1998;66(2):535-40; discussion 541.

Indeks‎: PubMed 9725399

https://www.ncbi.nlm.nih.gov/pubmed/9725399 (otvara novi prozor)

Efficacy of tranexamic acid as compared to aprotinin in open heart surgery in children. (otvara novi prozor)

Muthialu N, Balakrishnan S, Sundar R, Muralidharan S.

Izvor‎: Ann Card Anaesth 2015;18(1):23-6.

Indeks‎: PubMed 25566706

DOI‎: 10.4103/0971-9784.148316

https://www.ncbi.nlm.nih.gov/pubmed/25566706 (otvara novi prozor)

Comparative analysis of antifibrinolytic medications in pediatric heart surgery. (otvara novi prozor)

Pasquali SK, Li JS, He X, Jacobs ML, O'Brien SM, Hall M, Jaquiss RD, Welke KF, Peterson ED, Shah SS, Jacobs JP.

Izvor‎: J Thorac Cardiovasc Surg 2012;143(3):550-7.

Indeks‎: PubMed 22264414

DOI‎: 10.1016/j.jtcvs.2011.06.048

https://www.ncbi.nlm.nih.gov/pubmed/22264414 (otvara novi prozor)

The efficacy of tranexamic acid versus placebo in decreasing blood loss in pediatric patients undergoing repeat cardiac surgery. (otvara novi prozor)

Reid RW, Zimmerman AA, Laussen PC, Mayer JE, Gorlin JB, Burrows FA.

Izvor‎: Anesth Analg 1997;84(5):990-6.

Indeks‎: PubMed 9141920

https://www.ncbi.nlm.nih.gov/pubmed/9141920 (otvara novi prozor)

Effective tranexamic acid concentration for 95% inhibition of tissue-type plasminogen activator induced hyperfibrinolysis in children with congenital heart disease: A prospective, controlled, in-vitro study. (otvara novi prozor)

Rozen L, Faraoni D, Sanchez Torres C, Willems A, Noubouossie DC, Barglazan D, Van der Linden P, Demulder A.

Izvor‎: Eur J Anaesthesiol 2015;32(12):844-50.

Indeks‎: PubMed 26258658

DOI‎: 10.1097/EJA.0000000000000316

https://www.ncbi.nlm.nih.gov/pubmed/26258658 (otvara novi prozor)

Comparison of different doses of ε-aminocaproic acid in children for tetralogy of Fallot surgery: clinical efficacy and safety. (otvara novi prozor)

Sarupria A, Makhija N, Lakshmy R, Kiran U.

Izvor‎: J Cardiothorac Vasc Anesth 2013;27(1):23-9.

Indeks‎: PubMed 22995453

DOI‎: 10.1053/j.jvca.2012.07.001

https://www.ncbi.nlm.nih.gov/pubmed/22995453 (otvara novi prozor)

Comparison of three dose regimens of aprotinin in infants undergoing the arterial switch operation. (otvara novi prozor)

Verma YS, Chauhan S, Bisoi AK, Gharde P, Kiran U, Das SN.

Izvor‎: Ann Card Anaesth 2010;13(2):110-5.

Indeks‎: PubMed 20442540

DOI‎: 10.4103/0971-9784.62935

https://www.ncbi.nlm.nih.gov/pubmed/20442540 (otvara novi prozor)

Pharmacokinetics of tranexamic acid in neonates, infants, and children undergoing cardiac surgery with cardiopulmonary bypass. (otvara novi prozor)

Wesley MC, Pereira LM, Scharp LA, Emani SM, McGowan FX Jr, DiNardo JA.

Izvor‎: Anesthesiology 2015;122(4):746-58.

Indeks‎: PubMed 25585004

DOI‎: 10.1097/ALN.0000000000000570

https://www.ncbi.nlm.nih.gov/pubmed/25585004 (otvara novi prozor)

Efficacy and safety of aprotinin in neonatal congenital heart operations. (otvara novi prozor)

Wilder NS, Kavarana MN, Voepel-Lewis T, Paugh T, Lee T, Ohye RG.

Izvor‎: Ann Thorac Surg 2011;92(3):958-63.

Indeks‎: PubMed 21871283

DOI‎: 10.1016/j.athoracsur.2011.04.094

https://www.ncbi.nlm.nih.gov/pubmed/21871283 (otvara novi prozor)

The effect of preoperative tranexamic acid on blood loss after cardiac operations in children. (otvara novi prozor)

Zonis Z, Seear M, Reichert C, Sett S, Allen C.

Izvor‎: J Thorac Cardiovasc Surg 1996;111(5):982-7.

Indeks‎: PubMed 8622323

https://www.ncbi.nlm.nih.gov/pubmed/8622323 (otvara novi prozor)

Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery. (otvara novi prozor)

Agarwal HS, Bennett JE, Churchwell KB, Christian KG, Drinkwater DC Jr, He Y, Taylor MB.

Izvor‎: Ann Thorac Surg 2007;84(1):161-8.

Indeks‎: PubMed 17588404

DOI‎: 10.1016/j.athoracsur.2007.02.051

https://www.ncbi.nlm.nih.gov/pubmed/17588404 (otvara novi prozor)

Pediatric off-label use of recombinant factor VIIa. (otvara novi prozor)

Alten JA, Benner K, Green K, Toole B, Tofil NM, Winkler MK.

Izvor‎: Pediatrics 2009;123(3):1066-72.

Indeks‎: PubMed 19255041

DOI‎: 10.1542/peds.2008-1685

https://www.ncbi.nlm.nih.gov/pubmed/19255041 (otvara novi prozor)

Factor VII for excessive bleeding following congenital heart disease surgery. (otvara novi prozor)

Changlani DK, Devendaran V, Murmu UC, Ganesan S, Varghese R, Kumar RS.

Izvor‎: Asian Cardiovasc Thorac Ann 2012;20(2):120-5.

Indeks‎: PubMed 22499956

DOI‎: 10.1177/0218492311433614

https://www.ncbi.nlm.nih.gov/pubmed/22499956 (otvara novi prozor)

Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass. (otvara novi prozor)

Guzzetta NA, Huch S, Fernandez JD, Tosone SR, Miller BE.

Izvor‎: Paediatr Anaesth 2009;19(4):364-70.

Indeks‎: PubMed 19143947

DOI‎: 10.1111/j.1460-9592.2008.02905.x

https://www.ncbi.nlm.nih.gov/pubmed/19143947 (otvara novi prozor)

Review of the off-label use of recombinant activated factor VII in pediatric cardiac surgery patients. (otvara novi prozor)

Guzzetta NA, Russell IA, Williams GD.

Izvor‎: Anesth Analg 2012;115(2):364-78.

Indeks‎: PubMed 22652310

DOI‎: 10.1213/ANE.0b013e31825aff10

https://www.ncbi.nlm.nih.gov/pubmed/22652310 (otvara novi prozor)

Is recombinant activated factor VII effective in the treatment of excessive bleeding after paediatric cardiac surgery? (otvara novi prozor)

Okonta KE, Edwin F, Falase B.

Izvor‎: Interact Cardiovasc Thorac Surg 2012;15(4):690-4.

Indeks‎: PubMed 22811512

DOI‎: 10.1093/icvts/ivs309

https://www.ncbi.nlm.nih.gov/pubmed/22811512 (otvara novi prozor)

Cardiac surgery without blood products in a Jehovah's Witness child with factor VII deficiency. (otvara novi prozor)

Pérez-Ferrer A, Gredilla E, de Vicente J, Laporta Y.

Izvor‎: J Cardiothorac Vasc Anesth 2012;26(4):651-3.

Indeks‎: PubMed 21924639

DOI‎: 10.1053/j.jvca.2011.07.012

https://www.ncbi.nlm.nih.gov/pubmed/21924639 (otvara novi prozor)

Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass. (otvara novi prozor)

Pychyńska-Pokorska M, Pągowska-Klimek I, Krajewski W, Moll JJ.

Izvor‎: J Cardiothorac Vasc Anesth 2011;25(6):987-94.

Indeks‎: PubMed 21835642

DOI‎: 10.1053/j.jvca.2011.05.012

https://www.ncbi.nlm.nih.gov/pubmed/21835642 (otvara novi prozor)

Increased recombinant activated factor VII use and need for surgical reexploration following a switch from aprotinin to epsilon-aminocaproic acid in infant cardiac surgery. (otvara novi prozor)

Scott JP, Costigan DJ, Hoffman GM, Simpson PM, Dasgupta M, Punzalan R, Berens RJ, Tweddell JS, Stuth EA.

Izvor‎: J Clin Anesth 2014;26(3):204-11.

Indeks‎: PubMed 24809789

DOI‎: 10.1016/j.jclinane.2013.10.015

https://www.ncbi.nlm.nih.gov/pubmed/24809789 (otvara novi prozor)

Recombinant activated factor VII for hemorrhage after pediatric cardiac surgery. (otvara novi prozor)

Singh SP, Chauhan S, Choudhary M, Vasdev S, Talwar S.

Izvor‎: Asian Cardiovasc Thorac Ann 2012;20(1):19-23.

Indeks‎: PubMed 22371937

DOI‎: 10.1177/0218492311432584

https://www.ncbi.nlm.nih.gov/pubmed/22371937 (otvara novi prozor)

Recombinant factor VIIa to treat bleeding after cardiac surgery in an infant. (otvara novi prozor)

Tobias JD, Berkenbosch JW, Russo P.

Izvor‎: Pediatr Crit Care Med 2003;4(1):49-51.

Indeks‎: PubMed 12656542

DOI‎: 10.1097/01.PCC.0000031472.55687.4E

https://www.ncbi.nlm.nih.gov/pubmed/12656542 (otvara novi prozor)

Recombinant factor VIIa to control excessive bleeding following surgery for congenital heart disease in pediatric patients. (otvara novi prozor)

Tobias JD, Simsic JM, Weinstein S, Schechter W, Kartha V, Michler R.

Izvor‎: J Intensive Care Med 2004;19(5):270-3.

Indeks‎: PubMed 15358945

DOI‎: 10.1177/0885066604267783

https://www.ncbi.nlm.nih.gov/pubmed/15358945 (otvara novi prozor)

Recombinant activated factor VII in cardiac surgery: a systematic review. (otvara novi prozor)

Warren O, Mandal K, Hadjianastassiou V, Knowlton L, Panesar S, John K, Darzi A, Athanasiou T.

Izvor‎: Ann Thorac Surg 2007;83(2):707-14.

Indeks‎: PubMed 17258029

DOI‎: 10.1016/j.athoracsur.2006.10.033

https://www.ncbi.nlm.nih.gov/pubmed/17258029 (otvara novi prozor)

Defining the role of recombinant activated factor VII in pediatric cardiac surgery: where should we go from here? (otvara novi prozor)

Warren OJ, Rogers PL, Watret AL, de Wit KL, Darzi AW, Gill R, Athanasiou T.

Izvor‎: Pediatr Crit Care Med 2009;10(5):572-82.

Indeks‎: PubMed 19451849

DOI‎: 10.1097/PCC.0b013e3181a642d5

https://www.ncbi.nlm.nih.gov/pubmed/19451849 (otvara novi prozor)

Decreasing the need for transfusion: infant cardiac surgery using hemodilution and recombinant factor VIIa. (otvara novi prozor)

Winch PD, Naguib AN, Bradshaw JR, Galantowicz M, Tobias JD.

Izvor‎: Pediatr Cardiol 2013;34(1):119-24.

Indeks‎: PubMed 22760694

DOI‎: 10.1007/s00246-012-0398-1

https://www.ncbi.nlm.nih.gov/pubmed/22760694 (otvara novi prozor)

Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder. (otvara novi prozor)

Yilmaz D, Karapinar B, Balkan C, Akisü M, Kavakli K.

Izvor‎: Pediatr Hematol Oncol 2008;25(4):301-11.

Indeks‎: PubMed 18484474

DOI‎: 10.1080/08880010802016904

https://www.ncbi.nlm.nih.gov/pubmed/18484474 (otvara novi prozor)

Perioperative monitoring of thromboelastograph on blood protection and recovery for severely cyanotic patients undergoing complex cardiac surgery. (otvara novi prozor)

Cui Y, Hei F, Long C, Feng Z, Zhao J, Yan F, Wang Y, Liu J.

Izvor‎: Artif Organs 2010;34(11):955-60.

Indeks‎: PubMed 21092037

DOI‎: 10.1111/j.1525-1594.2010.01148.x

https://www.ncbi.nlm.nih.gov/pubmed/21092037 (otvara novi prozor)

Plasma fibrinogen concentration is correlated with postoperative blood loss in children undergoing cardiac surgery. A retrospective review. (otvara novi prozor)

Faraoni D, Willems A, Savan V, Demanet H, De Ville A, Van der Linden P.

Izvor‎: Eur J Anaesthesiol 2014;31(6):317-26.

Indeks‎: PubMed 24503704

DOI‎: 10.1097/EJA.0000000000000043

https://www.ncbi.nlm.nih.gov/pubmed/24503704 (otvara novi prozor)

Efficacy and safety of fibrinogen concentrate in surgical patients: a meta-analysis of randomized controlled trials. (otvara novi prozor)

Fominskiy E, Nepomniashchikh VA, Lomivorotov VV, Monaco F, Vitiello C, Zangrillo A, Landoni G.

Izvor‎: J Cardiothorac Vasc Anesth 2016;30(5):1196-204.

Indeks‎: PubMed 27493092

DOI‎: 10.1053/j.jvca.2016.04.015

https://www.ncbi.nlm.nih.gov/pubmed/27493092 (otvara novi prozor)

Hemostatic effects of fibrinogen concentrate compared with cryoprecipitate in children after cardiac surgery: a randomized pilot trial. (otvara novi prozor)

Galas FR, de Almeida JP, Fukushima JT, Vincent JL, Osawa EA, Zeferino S, Câmara L, Guimarães VA, Jatene MB, Hajjar LA.

Izvor‎: J Thorac Cardiovasc Surg 2014;148(4):1647-55.

Indeks‎: PubMed 24951020

DOI‎: 10.1016/j.jtcvs.2014.04.029

https://www.ncbi.nlm.nih.gov/pubmed/24951020 (otvara novi prozor)

Four-factor prothrombin complex concentrates in paediatric patients—a retrospective case series. (otvara novi prozor)

Noga T, Bruce AA, Blain H, Nahirniak S.

Izvor‎: Vox Sang 2016;110(3):253-7.

Indeks‎: PubMed 26509839

DOI‎: 10.1111/vox.12353

https://www.ncbi.nlm.nih.gov/pubmed/26509839 (otvara novi prozor)

Minimizing perioperative blood loss and transfusions in children. [Réduire les pertes sanguines et les besoins transfusionnels en chirurgie pédiatrique.] [English, French abstract] (otvara novi prozor)

Guay J, de Moerloose P, Lasne D.

Izvor‎: Can J Anaesth 2006;53(6 Suppl):S59-67.

Indeks‎: PubMed 16766791

https://www.ncbi.nlm.nih.gov/pubmed/16766791 (otvara novi prozor)

Anesthetic management in a pediatric patient with Noonan syndrome, mastocytosis, and von Willebrand disease: a case report. (otvara novi prozor)

Macksey LF, White B.

Izvor‎: AANA J 2007;75(4):261-4.

Indeks‎: PubMed 17711156

https://www.ncbi.nlm.nih.gov/pubmed/17711156 (otvara novi prozor)

A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. (otvara novi prozor)

Achneck HE, Sileshi B, Jamiolkowski RM, Albala DM, Shapiro ML, Lawson JH.

Izvor‎: Ann Surg 2010;251(2):217-28.

Indeks‎: PubMed 20010084

DOI‎: 10.1097/SLA.0b013e3181c3bcca

https://www.ncbi.nlm.nih.gov/pubmed/20010084 (otvara novi prozor)

Resternotomy in pediatric cardiac surgery: CoSeal initial experience. (otvara novi prozor)

Pace Napoleone C, Oppido G, Angeli E, Gargiulo G.

Izvor‎: Interact Cardiovasc Thorac Surg 2007;6(1):21-3.

Indeks‎: PubMed 17669759

DOI‎: 10.1510/icvts.2006.141531

https://www.ncbi.nlm.nih.gov/pubmed/17669759 (otvara novi prozor)

Utility of Sonoclot analysis and tranexamic acid in tetralogy of Fallot patients undergoing intracardiac repair. (otvara novi prozor)

Aggarwal V, Kapoor PM, Choudhury M, Kiran U, Chowdhury U.

Izvor‎: Ann Card Anaesth 2012;15(1):26-31.

Indeks‎: PubMed 22234018

DOI‎: 10.4103/0971-9784.91477

https://www.ncbi.nlm.nih.gov/pubmed/22234018 (otvara novi prozor)

Perioperative monitoring of thromboelastograph on blood protection and recovery for severely cyanotic patients undergoing complex cardiac surgery. (otvara novi prozor)

Cui Y, Hei F, Long C, Feng Z, Zhao J, Yan F, Wang Y, Liu J.

Izvor‎: Artif Organs 2010;34(11):955-60.

Indeks‎: PubMed 21092037

DOI‎: 10.1111/j.1525-1594.2010.01148.x

https://www.ncbi.nlm.nih.gov/pubmed/21092037 (otvara novi prozor)

Thromboelastometry-guided intraoperative haemostatic management reduces bleeding and red cell transfusion after paediatric cardiac surgery. (otvara novi prozor)

Nakayama Y, Nakajima Y, Tanaka KA, Sessler DI, Maeda S, Iida J, Ogawa S, Mizobe T.

Izvor‎: Br J Anaesth 2015;114(1):91-102.

Indeks‎: PubMed 25303988

DOI‎: 10.1093/bja/aeu339

https://www.ncbi.nlm.nih.gov/pubmed/25303988 (otvara novi prozor)